SynAct Pharma AB
http://www.synactpharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From SynAct Pharma AB
SynAct Surveys Its Options As Rheumatoid Arthritis Asset Succeeds At Phase II
The company’s lead candidate, AP1189, has shown promise in a mid-stage rheumatoid arthritis study, sparking plans for an imminent strategic business collaboration.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice